Eevia Health Plc’s has received an order from a US company for Fenoprolic 70 Organic, an organically certified pine bark extract.
The customer is a medium-sized US contract manufacturer that manufactures consumer-ready dosage forms, such as tablets, lozenges, hard-gel capsules, and similar, for various brand holders across North America. The contract manufacturer also has its own brand.
The product is Eevia’s ingredient Fenoprolic 70 Organic, which is a highly concentrated and organically certified pine bark extract with 70% oligomeric proanthocyanidins or OPCs as these are called in the industry.
“Although we were in contact some years ago, before Covid, we see this as the first order from this customer. Although the order is small, we are excited, because the contract manufacturer serves several large brands, and our pine bark extract has the potential to compete well. The customer is excited in general about our polyphenol products, and we expect further orders during 2024,” states Anna-Maija Vanhatalo, Sales Manager at Eevia Health.
Eevia Health is a manufacturer of 100% organically certified plant extracts.
